(Q42635940)

4 November 2017

Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia (English)

1 reference

4 November 2017

1 reference

1

Siegfried Kasper

0 references

language of work or name

1 reference

1 January 2004

1 reference

4 November 2017

Depression and Anxiety

1 reference

4 November 2017

20

1 reference

4 November 2017

1

1 reference

4 November 2017

44-47

1 reference

A comparative study of haloperidol and diazepam in the treatment of anxiety

4 November 2017

1 reference

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

21 January 2018

1 reference

7 January 2021

A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia

1 reference

7 January 2021

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

7 January 2021

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder

1 reference

7 January 2021

A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia

1 reference

7 January 2021

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics.

1 reference

7 January 2021

Quality of life in schizophrenia: contributions of anxiety and depression

1 reference

7 January 2021

Progress defined--short-term efficacy, long-term effectiveness

1 reference

7 January 2021

A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia

1 reference

7 January 2021

Good tolerability equals good results: the patient's perspective

1 reference

7 January 2021

Quality of life in first-admitted schizophrenia patients: a follow-up study

1 reference

7 January 2021

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20017

1 reference

4 November 2017

1 reference

PubMed ID

15368596